Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma

about

Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma

Item

http://www.wikidata.org/entity/Q58693989

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 22 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@en

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@nl

type

Item

label

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@en

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@nl

prefLabel

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@en

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@nl

P1476

Pleiotropic Effects of Heparin ...... ms in Hepatocellular Carcinoma

@en

P2093

Ayşim Güneş

http://www.w3.org/2001/XMLSchema#string

Ezgi Bağırsakçı

http://www.w3.org/2001/XMLSchema#string

Peyda Korhan

http://www.w3.org/2001/XMLSchema#string

Yeliz Yılmaz

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials

Sorafenib in advanced hepatocellular carcinoma

Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016

Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system

Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

P304

7568742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/7568742

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Brian I. Carr

Hande Topel

Neşe Atabey

P577

2018-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30425976

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

hepatocellular carcinoma

gastroenterology

liver neoplasm

P932

6217885

http://www.w3.org/2001/XMLSchema#string